Singapore markets close in 3 hours 19 minutes
Straits Times Index
3,308.96 +8.96 (+0.27%) Nikkei
38,621.69 -11.33 (-0.03%) Hang Seng
18,055.90 -279.42 (-1.52%) FTSE 100
8,272.46 +67.35 (+0.82%) Bitcoin USD
64,559.81 -811.82 (-1.24%) CMC Crypto 200
1,351.52 -31.15 (-2.25%)
Cerevel Therapeutics Holdings, Inc. (CERE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.60B |
| Enterprise value | 7.12B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 13.46 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -12.80 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.42 |
| 52-week change 3 | 28.80% |
| S&P500 52-week change 3 | 25.87% |
| 52-week high 3 | 43.59 |
| 52-week low 3 | 19.59 |
| 50-day moving average 3 | 41.70 |
| 200-day moving average 3 | 35.88 |
Share statistics
| Avg vol (3-month) 3 | 1.13M |
| Avg vol (10-day) 3 | 1.33M |
| Shares outstanding 5 | 182.2M |
| Implied shares outstanding 6 | 182.2M |
| Float 8 | 77.82M |
| % held by insiders 1 | 15.32% |
| % held by institutions 1 | 85.29% |
| Shares short (15 May 2024) 4 | 7.11M |
| Short ratio (15 May 2024) 4 | 7.39 |
| Short % of float (15 May 2024) 4 | 8.18% |
| Short % of shares outstanding (15 May 2024) 4 | 3.90% |
| Shares short (prior month 15 Apr 2024) 4 | 7.92M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -29.79% |
| Return on equity (ttm) | -92.45% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -484.52M |
| Net income avi to common (ttm) | -460.47M |
| Diluted EPS (ttm) | -2.73 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 846.29M |
| Total cash per share (mrq) | 4.64 |
| Total debt (mrq) | 482.3M |
| Total debt/equity (mrq) | 85.44% |
| Current ratio (mrq) | 10.22 |
| Book value per share (mrq) | 3.10 |
Cash flow statement
| Operating cash flow (ttm) | -367.05M |
| Levered free cash flow (ttm) | -212.07M |
© 2024 Yahoo. All rights reserved.